SCHEMBL5364636

SCHEMBL5364636

Oc1nc(O)c2[nH]nc(-c3ccccc3)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 1/20 0.43
YTHDF2 Q9Y5A9 1/20 0.43
ALDH1A1 P00352 5/20 0.42
MAPT P10636 2/20 0.42
GFER P55789 1/20 0.42
KDM4E B2RXH2 5/20 0.41
HPGD P15428 3/20 0.41
GAA P10253 2/20 0.41
MAPK10 P53779 2/20 0.41
ALPL P05186 1/20 0.41
IDO1 P14902 1/20 0.41
TTK P33981 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CSF1R P07333 1/20 0.40
PDGFRB P09619 1/20 0.40
KIT P10721 1/20 0.40
FLT3 P36888 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
RAB9A P51151 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784644 0.73 ALDH1A1 (0.42) ALDH1A1MAPTGFERKDM4EHPGD
SCHEMBL4717637 0.72 ALDH1A1 (0.53) YTHDC1YTHDF2ALDH1A1MAPTGFER
SCHEMBL10611638 0.71 NR1H2 (0.42) HPGDALPLMEN1KMT2ARAB9A
SCHEMBL5358160 0.70 ALDH1A1 (0.46) YTHDC1YTHDF2ALDH1A1MAPTGFER
SCHEMBL3533590 0.67 PIK3CG (0.50) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL10567463 0.67 HPGD (0.46) YTHDC1YTHDF2ALDH1A1MAPTGFER
SCHEMBL1785972 0.65 ALDH1A1 (0.50) ALDH1A1MAPTGFERKDM4EHPGD
SCHEMBL8081940 0.65 ALDH1A1 (0.50) ALDH1A1MAPTGFERKDM4EHPGD
SCHEMBL1528572 0.63 ALDH1A1 (0.60) ALDH1A1MAPTGFERKDM4EHPGD
SCHEMBL15713879 0.63 MEN1 (0.49) ALDH1A1MAPTGFERKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814885-A2 NOVEL BICYCLIC HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM Reddy US Therapeutics, Inc. (US) 2007-08-08 EP disclosed
WO-2006073610-A2 NOVEL BICYCLIC HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM REDDY US THERAPEUTICS, INC. (US) 2006-07-13 WO disclosed
US-20060128729-A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them DR. REDDY'S LABORATORIES LTD. (IN) 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128729-A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them HPSE, ENGASE, UGCG YTHDC1 3331/4885YTHDF2 4250/4885ALDH1A1 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.